SHL Telemedicine Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-7.06	-0.08	-14.11	0.28	5.7
Depreciation & Amortization	7.69	7.13	5.38	4.93	3.92
Share-Based Compensation	1.25	1.76	1.29	0.08	0.23
Other Operating Activities	-3.38	-8.89	7.62	-0.61	1.01
Operating Cash Flow	-1.5	-0.07	0.19	4.68	10.85
Operating Cash Flow Growth	-	-	-96.05%	-56.85%	-
Capital Expenditures	-5.49	-6.9	-3.26	-1.77	-1.97
Acquisitions	0	0	-27.32	0	0
Change in Investments	-3.85	0.47	-10.39	-5.88	4.45
Investing Cash Flow	-9.35	-6.43	-40.97	-7.65	2.47
Dividends Paid	0	0	0	0	-10.5
Share Issuance / Repurchase	20.3	1.96	30.6	0	0
Debt Issued / Paid	-4.72	-4.11	16.33	0.72	-1.39
Other Financing Activities	-1.91	-0.13	4.14	-	-
Financing Cash Flow	13.67	-2.28	51.08	0.72	-11.89
Exchange Rate Effect	-0.62	-1.58	0.41	0.31	0.22
Net Cash Flow	2.21	-10.36	10.7	-1.93	1.65
Free Cash Flow	-6.99	-6.98	-3.07	2.91	8.88
Free Cash Flow Growth	-	-	-	-67.21%	-
Free Cash Flow Margin	-12.24%	-11.83%	-6.20%	7.25%	21.19%
Free Cash Flow Per Share	-0.43	-0.48	-0.21	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).